Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN566378 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-E2F Transcription Factor 8 (E2F8) (AA 1-431), (full length) antibody
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-431, full length
- Isotype
- IgG
- Antibody clone number
- 3E9-2F5
- Vial size
- 100 μg
- Storage
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
- Handling
- Aliquot to avoid repeated freezing and thawing.
Submitted references Genome-wide analysis reveals NRP1 as a direct HIF1α-E2F7 target in the regulation of motorneuron guidance in vivo.
E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation.
DNA-damage response control of E2F7 and E2F8.
Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development.
de Bruin A, A Cornelissen PW, Kirchmaier BC, Mokry M, Iich E, Nirmala E, Liang KH, D Végh AM, Scholman KT, Groot Koerkamp MJ, Holstege FC, Cuppen E, Schulte-Merker S, Bakker WJ
Nucleic acids research 2016 May 5;44(8):3549-66
Nucleic acids research 2016 May 5;44(8):3549-66
E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation.
Deng Q, Wang Q, Zong WY, Zheng DL, Wen YX, Wang KS, Teng XM, Zhang X, Huang J, Han ZG
Cancer research 2010 Jan 15;70(2):782-91
Cancer research 2010 Jan 15;70(2):782-91
DNA-damage response control of E2F7 and E2F8.
Zalmas LP, Zhao X, Graham AL, Fisher R, Reilly C, Coutts AS, La Thangue NB
EMBO reports 2008 Mar;9(3):252-9
EMBO reports 2008 Mar;9(3):252-9
Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development.
Li J, Ran C, Li E, Gordon F, Comstock G, Siddiqui H, Cleghorn W, Chen HZ, Kornacker K, Liu CG, Pandit SK, Khanizadeh M, Weinstein M, Leone G, de Bruin A
Developmental cell 2008 Jan;14(1):62-75
Developmental cell 2008 Jan;14(1):62-75
No comments: Submit comment
No validations: Submit validation data